CIPROFLOXACIN THERAPY IN CYSTIC-FIBROSIS

被引：21

作者：

RAEBURN, JA

GOVAN, JRW

MCCRAE, WM

GREENING, AP

COLLIER, PS

HODSON, ME

GOODCHILD, MC

机构：

[1] UNIV EDINBURGH,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND

[2] QUEENS UNIV BELFAST,BELFAST BT7 1NN,ANTRIM,NORTH IRELAND

[3] UNIV HOSP WALES,CARDIFF CF4 4XW,S GLAM,WALES

[4] CARDIOTHORAC INST,LONDON SW3 6HP,ENGLAND

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1987年 / 20卷 / 03期

关键词：

D O I：

10.1093/jac/20.3.295

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：295 / 296

页数：2

共 8 条

[1]

ALFAHAM M, 1986, 14TH P ANN M EUR WOR, P58

[2] CIPROFLOXACIN DISK SUSCEPTIBILITY TESTS - INTERPRETIVE ZONE SIZE STANDARDS FOR 5-MU-G DISKS [J].

BARRY, AL ;

FASS, RJ ;

ANHALT, JP ;

NEU, HC ;

THORNSBERRY, C ;

TILTON, RC ;

PAINTER, BG ;

WASHINGTON, JA .

JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 21 (06) :880-883

[3] CIPROFLOXACIN PHARMACOKINETICS IN PATIENTS WITH CYSTIC-FIBROSIS [J].

BENDER, SW ;

DALHOFF, A ;

SHAH, PM ;

STREHL, R ;

POSSELT, HG .

INFECTION, 1986, 14 (01) :17-21

[4] SINGLE-DOSE PHARMACOKINETICS OF ORAL CIPROFLOXACIN IN PATIENTS WITH CYSTIC-FIBROSIS [J].

GOLDFARB, J ;

WORMSER, GP ;

INCHIOSA, MA ;

GUIDERI, G ;

DIAZ, M ;

GANDHI, R ;

GOLTZMAN, C ;

MASCIA, AV .

JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (03) :222-226

[5]

GOVAN JRW, 1986, MICROBIOL SCI, V3, P302

[6]

GOVAN JRW, 1985, 14TH P INT C CHEM TO, P357

[7]

HODSON ME, 1987, LANCET, V1, P235

[8]

SCULLY BE, 1986, LANCET, V1, P819

← 1 →